HomeNASDAQ:MRNA

NASDAQ:MRNA

Moderna Stock Rises on Positive Business Outlook

Moderna Stock Rises on Positive Business Outlook

January 10, 2023

Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022

Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022

January 9, 2023

Moderna Stock Goes up Because the Combination of an MRNA Vaccine and Keytruda Showed Promise in a Trial for Skin Cancer

Moderna Stock Goes up Because the Combination of an MRNA Vaccine and Keytruda Showed Promise in a Trial for Skin Cancer

December 14, 2022

Moderna Stock Went Up Because It Is Joining Hands With the US to Make Shots to Fight Ebola and Other Threats

Moderna Stock Went Up Because It Is Joining Hands With the US to Make Shots to Fight Ebola and Other Threats

October 26, 2022

Moderna Stock Slid as Omicron BA.1 Bivalent Vaccine Better Than the Initial Shot as a Fourth Booster

Moderna Stock Slid as Omicron BA.1 Bivalent Vaccine Better Than the Initial Shot as a Fourth Booster

October 20, 2022

Moderna Stock Stayed Flat as It Asked FDA to Approve Enhanced COVID Boosters for Kids.

September 25, 2022

Is Moderna Stock a Buy Now With the FDA Approval?

Is Moderna Stock a Buy Now With the FDA Approval?

September 21, 2022

The Reason Why Moderna Stock Was the Best Performer on the Market on Tuesday

September 20, 2022

Moderna Stock on the Rise After Lockdowns in China

Moderna Stock on the Rise After Lockdowns in China

September 14, 2022

Moderna Stock Is Trading Upwards as CEO Confirms Plans for Mrna Factory in Japan

Moderna Stock Is Trading Upwards as CEO Confirms Plans for Mrna Factory in Japan

September 14, 2022

« 1 2 3 »